Anticholinergic drugs

The aim of a study was to compare the safety and efficacy of Botulinum toxin type-A ( BTX-A ) versus...


Chronic obstructive pulmonary disease ( COPD ) is characterized by persistent airflow limitation caused by bronchial alterations, small airways disease...


People with central neurological disease or injury have a much higher risk of both faecal incontinence and constipation than the...


Parkinson disease is the second most common neurodegenerative disease worldwide. Although no available therapies alter the underlying neurodegenerative process, symptomatic...


The results from SETTLE phase III study with Safinamide were presented at the 17th International Congress of Parkinson’s disease and...


Around 16% to 45% of adults have overactive bladder symptoms, urgency with frequency or urgency urinary incontinence, or both, termed...


Chronic obstructive pulmonary disease ( COPD ) is a leading cause of death worldwide, and the rate of COPD-related death...


Anticholinergic drugs may cause older people to experience greater decline in their thinking skills than people not taking the drugs,...


Anticholinergic drugs may cause older people to experience greater decline in their thinking skills than people not taking the drugs,...


Sunovion Pharmaceuticals has announced that the FDA ( Food and Drug Administration ) has approved Latuda ( Lurasidone HCl )...


A study looked at the effects of taking a medication with anticholinergic properties on the annual change in thinking abilities...


The U.S. FDA ( Food and Drug Administration ) approved Aripiprazole ( Abilify ) for maintaining efficacy in patients with...


In two double-blind, randomized, multicenter studies evaluated the investigational use of intramuscular ( IM ) Aripiprazole ( Abilify ) in...